• All
  • Article Title
  • Abstract
  • Keywords
  • Author
  • Institution
  • Special Issue Topic

    Immunotherapy for Cancer of Digestive System

    Submission Deadline: October 31, 2024

    Guest Editor

    Prof. Evgeny Imyanitov E-Mail

    Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russian Federation

    Research Keywords: immune checkpoint inhibitors, microsatellite instability, mismatch repair deficiency, tumor mutation burden, PD-L1, esophageal cancer, gastric cancer, hepatobiliary cancer, colorectal cancer


    About the Special Issue

    Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment. These drugs antagonize immune-suppressive molecules and restore antitumor defense. ICIs are currently utilized for the management of a wide variety of gastrointestinal malignancies, including esophageal, gastric, hepatobiliary and colorectal cancers. The administration of ICIs often relies on the evaluation of predictive markers, particularly microsatellite instability (mismatch repair deficiency), tumor mutation burden and PD-L1 expression. ICIs are being intensively investigated in combination with other anticancer drugs, particularly cytotoxic and targeted agents. This issue is dedicated to the discussion on various aspects of immune therapy for gastrointestinal malignancies.

    Keywords: immune checkpoint inhibitors, microsatellite instability, mismatch repair deficiency, tumor mutation burden, PD-L1, esophageal cancer, gastric cancer, hepatobiliary cancer, colorectal cancer

    Call for Papers

    Published Articles

    Open Access
    Original Article
    Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
    Aim: Selecting patients for immunotherapy in metastatic gastric cancer (mGC) in second and subsequent lines remains challenging. The aim of our study is to assess the feasibility of anti-programm [...] Read more.
    Anastasia Rays ... Аlexey Tryakin
    Published: March 27, 2025 Explor Dig Dis. 2025;4:100568
    DOI: https://doi.org/10.37349/edd.2025.100568
    View:48
    Download:8
    Times Cited: 0
    Open Access
    Review
    Current efficacy of immune checkpoint inhibitors in microsatellite unstable colorectal cancer and potential biomarkers
    Microsatellite unstable (MSI) colorectal cancer (CRC) tumors have a high mutational load (particularly frame-shift mutations) that creates numerous neoantigens that are presented to major histocompa [...] Read more.
    Mariam Rojas ... Joan Maurel
    Published: February 18, 2025 Explor Dig Dis. 2025;4:100564
    DOI: https://doi.org/10.37349/edd.2025.100564
    View:436
    Download:12
    Times Cited: 0